{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:23Z","timestamp":1792074383048,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cancer Center Support Grant from the National Institutes of Health","award":["CA16672"],"award-info":[{"award-number":["CA16672"]}]},{"name":"NIH P30","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]},{"name":"MD Anderson Clinical Research Funding Award Program"},{"name":"German German Research Foundation","award":["GZ:HE 6824\/5-1"],"award-info":[{"award-number":["GZ:HE 6824\/5-1"]}]},{"name":"Seoul National University Hospital Research Fund","award":["30-2016-0250"],"award-info":[{"award-number":["30-2016-0250"]}]},{"name":"Institute for Information and Communications Technology Promotion (IITP) grant funded by the Korea government","award":["2018-0-00861"],"award-info":[{"award-number":["2018-0-00861"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA16672"],"award-info":[{"award-number":["CA16672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH P30","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]},{"name":"MD Anderson Clinical Research Funding Award Program"},{"name":"German German Research Foundation","award":["GZ:HE 6824\/5-1"],"award-info":[{"award-number":["GZ:HE 6824\/5-1"]}]},{"name":"Seoul National University Hospital Research Fund","award":["30-2016-0250"],"award-info":[{"award-number":["30-2016-0250"]}]},{"name":"Institute for Information and Communications Technology Promotion (IITP) grant funded by the Korea government","award":["2018-0-00861"],"award-info":[{"award-number":["2018-0-00861"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejca.2020.11.006","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T03:59:45Z","timestamp":1607399985000},"page":"134-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy"],"prefix":"10.1016","volume":"143","author":[{"given":"Andr\u00e9","family":"Pfob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-7305","authenticated-orcid":false,"given":"Chris","family":"Sidey-Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Byoel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios Konstantinos","family":"Tasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Koelbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-0060","authenticated-orcid":false,"given":"Michael","family":"Golatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiane M.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Paul","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M.","family":"Kuerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-9099","authenticated-orcid":false,"given":"Joerg","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.11.006_bib1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(18)30570-9","article-title":"Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"van Ramshorst","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib3","doi-asserted-by":"crossref","first-page":"26406","DOI":"10.18632\/oncotarget.25413","article-title":"Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy","volume":"9","author":"Santonja","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.11.006_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","article-title":"Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy","volume":"170","author":"Haque","year":"2018","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2020.11.006_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"163","author":"Goorts","year":"2017","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2020.11.006_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib8","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2020.11.006_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.11.006_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2017170180","article-title":"Imaging neoadjuvant therapy response in breast cancer","volume":"285","author":"Fowler","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2020.11.006_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2214\/AJR.16.17223","article-title":"Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer","volume":"208","author":"Rauch","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejca.2020.11.006_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2016.09.034","article-title":"Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?","volume":"69","author":"Heil","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2020.11.006_bib13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/SLA.0000000000002313","article-title":"A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can Be eliminated following neoadjuvant systemic therapy","volume":"267","author":"Kuerer","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2020.11.006_bib14","article-title":"Diagnosing pathologic complete response in the breast after neoadjuvant systemic treatment of breast cancer patients by minimal invasive biopsy","volume":"272","author":"Heil","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2020.11.006_bib15","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS19-GS5-04","article-title":"Abstract GS5-04: accuracy of post-neoadjuvant chemotherapy image-guided breast biopsy to predict the presence of residual cancer: a multi-institutional pooled analysis","volume":"80","author":"Tasoulis","year":"2020","journal-title":"Canc Res"},{"key":"10.1016\/j.ejca.2020.11.006_bib16","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS19-GS5-05","article-title":"Abstract GS5-05: primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical\/radiological complete response after neoadjuvant chemotherapy (NCT) to exp","volume":"80","author":"Basik","year":"2020","journal-title":"Canc Res"},{"key":"10.1016\/j.ejca.2020.11.006_bib17","article-title":"Abstract GS5-06: towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment)","volume":"80","author":"Vrancken Peeters","year":"2020","journal-title":"Canc Res"},{"key":"10.1016\/j.ejca.2020.11.006_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-020-05678-3","article-title":"Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial","volume":"182","author":"Lee","year":"2020","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2020.11.006_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1055\/a-0646-4522","article-title":"Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-level, AWMF registry number 032\/045ol, december 2017) - Part 1 with recommendations for the screening, diagnosis and therapy of breast Ca","volume":"78","author":"W\u00f6ckel","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.ejca.2020.11.006_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2020.11.006_bib21","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/jama.2019.16489","article-title":"How to read articles that use machine learning: users' guides to the medical literature","volume":"322","author":"Liu","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.11.006_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejca.2020.11.006_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-019-0681-4","article-title":"Machine learning in medicine: a practical introduction","volume":"19","author":"Sidey-Gibbons","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejca.2020.11.006_bib25","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.520","article-title":"Towards data-driven decision-making for breast cancer patients undergoing mastectomy and reconstruction: prediction of individual patient-reported outcomes at two-year follow-up using machine learning","volume":"38","author":"Pfob","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.2047","article-title":"Machine learning algorithms to predict financial toxicity associated with breast cancer treatment","volume":"38","author":"Sidey-Gibbons","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Software"},{"key":"10.1016\/j.ejca.2020.11.006_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.ejca.2020.11.006_bib30","first-page":"785","article-title":"XGBoost: a scalable tree boosting system","volume":"13","author":"Chen","year":"2016","journal-title":"Proc. ACM SIGKDD Int. Conf. Knowl. Discov.\u00a0Data Min."},{"key":"10.1016\/j.ejca.2020.11.006_bib31","author":"Lundberg"},{"key":"10.1016\/j.ejca.2020.11.006_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022627411411","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach Learn"},{"key":"10.1016\/j.ejca.2020.11.006_bib33","first-page":"281","article-title":"Support vector method for function approximation, regression estimation and signal processing","volume":"9","author":"Vapnik","year":"1997","journal-title":"Adv Neural Inform Process Syst"},{"key":"10.1016\/j.ejca.2020.11.006_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"Lecun","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.11.006_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/35016072","article-title":"Digital selection and analogue amplification coexist in a cortex- inspired silicon circuit","volume":"405","author":"Hahnloser","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.11.006_bib36","article-title":"Deep sparse rectifier neural networks","volume":"15315\u2013323","author":"Glorot","year":"2011","journal-title":"Proc. Fourteenth Int. Conf. Artif. Intell. Stat. PMLR"},{"key":"10.1016\/j.ejca.2020.11.006_bib37","article-title":"Incorporating Nesterov momentum into Adam","author":"Dozat","year":"2016","journal-title":"Proc. Fourth Int. Conf. Learn. Represent."},{"key":"10.1016\/j.ejca.2020.11.006_bib38","author":"Ribeiro"},{"key":"10.1016\/j.ejca.2020.11.006_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib40","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2009.1568","article-title":"Prevalence of and factors associated with persistent pain following breast cancer surgery","volume":"302","author":"G\u00e4rtner","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.11.006_bib41","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1245\/s10434-019-07548-9","article-title":"A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction","volume":"26","author":"Flanagan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","article-title":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges","volume":"31","author":"Heil","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ejso.2020.03.208","article-title":"De-escalation towards omission is the tipping point of individualizing breast cancer surgery","volume":"46","author":"Heil","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib44","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2020.11.006_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.11.006_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.annonc.2020.05.021","article-title":"Patients should be the tipping point of individualizing breast cancer surgery: commentary on \u2018Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges","volume":"31","author":"Heil","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.annonc.2020.04.009","article-title":"Important considerations prior to elimination of breast cancer surgery after neoadjuvant systemic therapy: listening to what our patients want","volume":"31","author":"Caballero","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib48","unstructured":"Reimer T. Omission of SLNB in triple-negative and HER2-positive breast cancer patients with rCR and pCR in the breast after NAST. Clin Identifier NCT04101851 [n.d]."},{"key":"10.1016\/j.ejca.2020.11.006_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-016-0684-6","article-title":"Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials","volume":"18","author":"van la Parra","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2020.11.006_bib50","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1245\/s10434-019-07533-2","article-title":"Patient selection for clinical trials eliminating surgery for HER2-positive breast cancer treated with neoadjuvant systemic therapy","volume":"26","author":"Sun","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2020.11.006_bib51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10549-011-1621-0","article-title":"Responsiveness of Adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy\/trastuzumab treatment in early breast cancer-results from the GeparQuattro study (GBG 40)","volume":"132","author":"Von Minckwitz","year":"2012","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2020.11.006_bib52","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/S2589-7500(19)30123-2","article-title":"A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis","volume":"1","author":"Liu","year":"2019","journal-title":"Lancet Digit Heal"},{"key":"10.1016\/j.ejca.2020.11.006_bib53","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejca.2020.11.006_bib54","first-page":"156","article-title":"A majority of low (1-10%) er positive breast cancers behave like hormone receptor negative tumors","volume":"5","author":"Prabhu","year":"2014","journal-title":"J Canc"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920313253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920313253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:30:01Z","timestamp":1760733001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920313253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"alternative-id":["S0959804920313253"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.11.006","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}